Rusnak Jonas, Schupp Tobias, Weidner Kathrin, Ruka Marinela, Egner-Walter Sascha, Forner Jan, Schmitt Alexander, Akin Muharrem, Tajti Péter, Mashayekhi Kambis, Ayoub Mohamed, Akin Ibrahim, Behnes Michael
Department of Cardiology, Angiology, Haemostaseology and Medical Intensive Care, University Medical Centre Mannheim, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany.
Department of Cardiology and Angiology, Hannover Medical School, Hannover, Germany.
Crit Care Med. 2025 Jan 1;53(1):e54-e64. doi: 10.1097/CCM.0000000000006459. Epub 2024 Oct 29.
The study investigates the prognostic impact of right bundle branch block (RBBB) and left bundle branch block (LBBB) in patients with cardiogenic shock (CS) compared with no bundle branch block (BBB). In patients with heart failure, existence of RBBB and LBBB has influence on prognosis.
Prospective registry-study.
ICU of a tertiary academic hospital in Germany.
Adult patients with CS.
None.
Consecutive patients with CS were included. The prognostic impact of RBBB and LBBB on 30-day all-cause mortality was tested within the entire cohort and in the subgroup of CS patients with cardiac arrest at admission. The final study cohort comprised 248 patients. Patients with RBBB showed the highest 30-day all-cause mortality followed by LBBB and no BBB (72.5% vs. 52.9% vs. 50.0%; log-rank p = 0.015). These findings were consistent even after solely including CS patients with cardiac arrest (90.0% vs. 73.3% vs. 62.2%; log-rank p = 0.008). After adjustment for lactate, norepinephrine, troponin I, Acute Physiology Score, Society of Cardiovascular Angiography & Interventions shock stage, and heart rate in a multivariable Cox regression analysis, RBBB still revealed a negative impact on 30-day all-cause mortality (hazard ratio [HR], 1.807; 95% CI, 1.107-2.947; p = 0.018), whereas LBBB was not associated with 30-day all-cause mortality. In this multivariable Cox regression model lactate (HR, 1.065; 95% CI, 1.018-1.115; p = 0.006), troponin I (HR, 1.003; 95% CI, 1.001-1.005; p = 0.001), and Acute Physiology Score (HR, 1.033; 95% CI, 1.001-1.066; p = 0.041) were as well associated with 30-day all-cause mortality. Finally, no association of RBBB was found with the incidence of liver or severe renal failure.
Besides the Acute Physiology Score, lactate, and troponin levels, RBBB was associated with an increased 30-day all-cause mortality in consecutive CS patients with and without cardiac arrest, whereas LBBB showed no prognostic impact.
本研究调查了心源性休克(CS)患者中右束支传导阻滞(RBBB)和左束支传导阻滞(LBBB)与无束支传导阻滞(BBB)相比的预后影响。在心力衰竭患者中,RBBB和LBBB的存在会影响预后。
前瞻性注册研究。
德国一家三级学术医院的重症监护病房。
成年CS患者。
无。
纳入连续的CS患者。在整个队列以及入院时发生心脏骤停的CS患者亚组中,测试了RBBB和LBBB对30天全因死亡率的预后影响。最终研究队列包括248例患者。RBBB患者的30天全因死亡率最高,其次是LBBB和无BBB患者(72.5%对52.9%对50.0%;对数秩检验p = 0.015)。即使仅纳入心脏骤停的CS患者,这些结果仍然一致(90.0%对73.3%对62.2%;对数秩检验p = 0.008)。在多变量Cox回归分析中,对乳酸、去甲肾上腺素、肌钙蛋白I、急性生理评分、心血管造影和介入学会休克分期以及心率进行调整后,RBBB仍然显示对30天全因死亡率有负面影响(风险比[HR],1.807;95%置信区间,1.107 - 2.947;p = 0.018),而LBBB与30天全因死亡率无关。在这个多变量Cox回归模型中,乳酸(HR,1.065;95%置信区间,1.018 - 1.115;p = 0.006)、肌钙蛋白I(HR,1.003;95%置信区间,1.001 - 1.005;p = 0.001)和急性生理评分(HR,1.033;95%置信区间,1.001 - 1.066;p = 0.041)也与30天全因死亡率相关。最后,未发现RBBB与肝或严重肾衰竭的发生率有关。
除急性生理评分、乳酸和肌钙蛋白水平外,RBBB与有或无心脏骤停的连续CS患者30天全因死亡率增加相关,而LBBB未显示出预后影响。